To the original poster, who expressed confusion about the actual numbers and why they don't look like the numbers other post: your test results are displayed using the international measurement standards, which express numbers in mmol/L units. Where you see a 3-digit glucose or lipid number, that is being displayed in US measurement standards, which use mg/dL units.

Your numbers in the US standard come out to (approximately):
fasting serum glucose: 6.5 = 117
cholesterol: 3.5 = 135
triglycerides: .97 = 86
HDL: 1.25 = 48
LDL: 1.9 = 73

So your cholesterol numbers are pretty amazing! Seriously amazing. Cholesterol levels are most assuredly connected to diabetes; many diabetics do have elevated lipids. It's all part of the metabolic syndrome.

Your fasting glucose, while not spectacularly low like your lipids, is apparently much improved. It looks like you've been doing a lot of hard work and are now reaping the rewards. Congratulations!

According to the Ontario Health Insurance Program:

Research has indicated that Blood Glucose Test Strips (BGTS) have a limited benefit for many patients who do not take insulin to manage their diabetes. Based on best evidence, the government is introducing changes to the number of blood glucose test strips it will reimburse people with diabetes, while ensuring those who need test strips to help manage diabetes will continue to have access to them. The new changes are aligned with the Canadian Diabetes Association (CDA) for encouraging proper testing practices for optimal patient outcomes.

A July 2009, report from Canadian Agency for Drugs and Technologies in Health (CADTH) stated that blood glucose test strips, in practice, have a limited clinical benefit for many patients who are not on insulin. The CDA also published a commentary recognizing that some limits on the number of blood glucose test strips reimbursed for patients on oral anti-diabetes medications may be reasonable.

Well, now what? I'm not on insulin and I hope I can avoid it. The only measures I know of are BG and A1c. I do a fasting Blood Glucose every day, and I'm starting to add in another measurement an hour after lunch. How else would I track what's going on? Do you know where this research is?

The Diabetes Control and Complications trial, a 7-year multi-centre trial, reported a 60% reduction in risk for diabetic retinopathy, nephropathy, and neuropathy for people with type 1 diabetes who were given intensive treatment compared with those who were given standard treatment. Intensive therapy slowed progression of and delayed onset of these complications. Intensive treatment included three or more daily injections of insulin or the use of an insulin pump.

Similarly, the United Kingdom Prospective Diabetes Study (UKPDS), a large clinical trial of 3867 people aged 26 to 65 with type 2 diabetes, found that intensive glycemic control (maintaining A1C=7.0) compared with less intensive glycemic control (A1C=7.9) resulted in a 12% reduction in risk for any diabetes-related endpoint (sudden death, death from hyperglycaemia or hypoglycaemia, fatal or non-fatal myocardial infarction, angina, heart failure, stroke, renal failure, amputation of at least one digit) and a 37% reduced risk for the microvascular complications (retinopathy, nephropathy, and/or neuropathy).
Self-testing of blood glucose levels is a very important part of diabetes self-management and is particularly beneficial when the information is used to make timely adjustments to help regulate blood glucose levels.

For people with type 1 diabetes, self-monitoring blood glucose 3 or more times per day (using a glucose meter and testing strips) was associated with a 1.0% drop in A1C levels.

For people with type 2 diabetes who were being treated with oral anti-hyperglycemic medications, self-testing at least once a day was associated with a 0.6% drop in A1C levels compared with those who self-tested less frequently.
For people with type 2 diabetes who were not using medications, any frequency of testing resulted in 0.4% drop in A1C levels compared to those who did not self-test at all. As mentioned previously, a 1% drop in A1C levels reduced the risk of acute myocardial infarction by 14% and heart failure by 16%.

As outlined in Recommendation 5, only certain subsets of the population (predominantly those aged 65+, people requiring social assistance and people requiring insulin) are covered for glucose testing strips. These supplies are necessary for all people with diabetes to monitor their blood glucose levels. A recently-published Canadian study found that lack of insurance coverage for self-monitoring test strips was significantly associated with higher A1C levels, even after controlling for age, income level, education level and marital status.